Preoperative single-dose methylprednisolone versus placebo after major liver resection in adults: protocol for a randomised controlled trial

Alexsander K Bressan, Derek J Roberts, Sana U Bhatti, Elijah Dixon, Francis R Sutherland, Oliver F Bathe, Chad G Ball, Alexsander K Bressan, Derek J Roberts, Sana U Bhatti, Elijah Dixon, Francis R Sutherland, Oliver F Bathe, Chad G Ball

Abstract

Introduction: Although randomised controlled trials have demonstrated that preoperative glucocorticoids may improve postoperative surrogate outcomes among patients undergoing major liver resection, evidence supporting improved patient-important outcomes is lacking. This superiority trial aims to evaluate the effect of administration of a bolus of the glucocorticoid methylprednisolone versus placebo during induction of anaesthesia on postoperative morbidity among adults undergoing elective major liver resection.

Methods and analysis: This will be a randomised, dual-arm, parallel-group, superiority trial. All consecutive adults presenting to a large Canadian tertiary care hospital who consent to undergo major liver resection will be included. Patients aged <18 years and those currently receiving systemic corticosteroid therapy will be excluded. We will randomly allocate participants to a preoperative 500 mg intravenous bolus of methylprednisolone versus placebo. Surgical team members and outcome assessors will be blinded to treatment allocation status. The primary outcome measure will be postoperative complications. Secondary outcome measures will include mortality, the incidence of several specific postoperative complications, and blood levels of select proinflammatory cytokines, acute-phase proteins, and laboratory liver enzymes or function tests on postoperative days 0, 1, 2 and 5. The incidence of postoperative complications and mortality will be compared using Fisher's exact test, while the above laboratory measures will be compared using mixed-effects models with a subject-specific random intercept.

Ethics and dissemination: This trial will evaluate the protective effect of a single preoperative dose of methylprednisolone on the hazard of postoperative complications. A report releasing study results will be submitted for publication in an appropriate journal, approximately 3 months after finishing the data collection.

Trial registration number: NCT01997658; Pre-results.

Keywords: Liver resection; acute-phase response; hepatectomy; methylprednisolone; preoperative glucocorticoid; randomized controlled trial.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

References

    1. Tillett WS, Francis T Jr. Serological reactions in pneumonia with non-protein somatic fraction of pneumococcus. J Exp Med 1930;52:561–71. 10.1084/jem.52.4.561
    1. Baigrie RJ, Lamont PM, Kwiatkowski D et al. . Systemic cytokine response after major surgery. Br J Surg 1992;79:757–60. 10.1002/bjs.1800790813
    1. Castell JV, Gomez-Lechon MJ, David M et al. . Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 1989;242:237–9. 10.1016/0014-5793(89)80476-4
    1. Biffl WL, Moore EE, Moore FA et al. . Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996;224:647–64. 10.1097/00000658-199611000-00009
    1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54. 10.1056/NEJM199902113400607
    1. Steven M, Opal MD, Vera A et al. . Anti-inflammatory cytokines. Chest 2000;117:1162–72. 10.1378/chest.117.4.1162
    1. Shenkin A, Fraser WD, Series J et al. . The serum interleukin 6 response to elective surgery. Lymphokine Res 1989;8: 123–7.
    1. Pullicino EA, Carli F, Poole S et al. . The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphokine Res 1990;9:231–8.
    1. Cruickshank AM, Fraser WD, Burns HJ et al. . Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Lond) 1990;79:161–5. 10.1042/cs0790161
    1. Ohzato H, Yoshizaki K, Nishimoto N et al. . Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992;111:201–9.
    1. Szczepanik AM, Scislo L, Scully T et al. . IL-6 serum levels predict postoperative morbidity in gastric cancer patients. Gastric Cancer 2011;14:266–73. 10.1007/s10120-011-0039-z
    1. Wen XH, Kong HY, Zhu SM et al. . Plasma levels of tumor necrotic factor-alpha and interleukin-6, -8 during orthotopic liver transplantation and their relations to postoperative pulmonary complications. Hepatobiliary Pancreat Dis Int 2004;3:38–41.
    1. Wiezer MJ, Meijer C, Vuylsteke R et al. . Is major liver surgery associated with an increased systemic inflammatory response? A prospective comparison of hemihepatectomy and other major abdominal surgery. Liver 1999;19:220–7. 10.1111/j.1478-3231.1999.tb00039.x
    1. Balzan S, Belghiti J, Farges O et al. . The “50–50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005;242:824–8, discussion 8–9 10.1097/01.sla.0000189131.90876.9e
    1. Mullen JT, Ribero D, Reddy SK et al. . Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007;204:854–62; discussion 62–4 10.1016/j.jamcollsurg.2006.12.032
    1. Man K, Fan ST, Ng IO et al. . Tolerance of the liver to intermittent pringle maneuver in hepatectomy for liver tumors. Arch Surg 1999;134:533–9. 10.1001/archsurg.134.5.533
    1. Teoh NC. Hepatic ischemia reperfusion injury: contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection-the good, bad and deadly. J Gastroenterol Hepatol 2011;26(Suppl 1):180–7. 10.1111/j.1440-1746.2010.06584.x
    1. Fang H, Liu A, Dirsch O et al. . Serum LBP levels reflect the impaired synthetic capacity of the remnant liver after partial hepatectomy in rats. J Immunol Methods 2012;382:68–75. 10.1016/j.jim.2012.05.006
    1. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998;94:557–72. 10.1042/cs0940557
    1. Yamashita Y, Shimada M, Hamatsu T et al. . Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trial. Arch Surg 2001;136:328–33. 10.1001/archsurg.136.3.328
    1. Schmidt SC, Hamann S, Langrehr JM et al. . Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: results of a prospective randomized study. J Hepatobiliary Pancreat Surg 2007;14:484–92. 10.1007/s00534-006-1200-7
    1. Muratore A, Ribero D, Ferrero A et al. . Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. Br J Surg 2003;90:17–22. 10.1002/bjs.4055
    1. Aldrighetti L, Pulitano C, Arru M et al. . Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transpl 2006;12:941–9. 10.1002/lt.20745
    1. Shibata T, Mizuguchi T, Nakamura Y et al. . Low-dose steroid pretreatment ameliorates the transient impairment of liver regeneration. World J Gastroenterol 2012;18:905–14. 10.3748/wjg.v18.i9.905
    1. Richardson AJ, Laurence JM, Lam VW. Use of pre-operative steroids in liver resection: a systematic review and meta-analysis. HPB (Oxford) 2014;16:12–19. 10.1111/hpb.12066
    1. Dripps RD. New classification of physical status. Anesthesiology 1963;24:111.
    1. Rahbari NN, Garden OJ, Padbury R et al. . Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011;159:713–24. 10.1016/j.surg.2010.10.001
    1. Centers for Disease Control and Prevention. Pneumonia (ventilator-associated [VAP] and non-ventilator-associated pneumonia [PNEU] event. January 2015 (modified April 2015).
    1. Centers for Disease Control and Prevention. Urinary tract infection (catheter-associated urinary tract infection [CAUTI] and non-catheter-associated urinary tract infection [UTI]) and other urinary system infection [USI]) events. January 2015 (modified April 2015.
    1. Centers for Disease Control and Prevention. Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection). January 2015 (modified April 2015).
    1. Centers for Disease Control and Prevention. CDC/NHSN protocol corrections, clarification, and additions. April 2013.
    1. De JW, Bourcier K, Rijkers GT et al. . Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 2009;12:52..
    1. Baker HN, Murphy R, Lopez E et al. . Conversion of a capture ELISA to a Luminex xMAP assay using a multiplex antibody screening method. J Vis Exp 2012;(65):e4084.
    1. Ware JH. Linear models for the analysis of longitudinal studies. Am Stat 1985;14:95–101.
    1. Laird NM, Donnelly C, Ware JH. Longitudinal studies with continuous responses. Stat Methods Med Res 1992;1:225–47. 10.1177/096228029200100302
    1. Liu G, Gould AL. Comparison of alternative strategies for analysis of longitudinal trials with dropouts. J Biopharm Stat 2002;12:207–26. 10.1081/BIP-120015744
    1. Mallinckrodt CH, Clark WS, David SR. Accounting for dropout bias using mixed-effects models. J Biopharm Stat 2001;11:9–21. 10.1081/BIP-100104194

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren